Analysis of Beximco Pharma, Bangladesh, 2023 Case Study
Key Learning Outcomes
By the end of the case, students should be able to:
- Understand the broad macro and micro environment of Beximco Pharma across its major markets with a focus on the challenges faced by the company.
- Evaluate Beximco Pharma's strategy and business environment in order to identify issues, risks, and opportunities and how they affect its operations and strategic position in a market, using concepts such as PESTLE, SWOT, Porter's Five Forces, VRIO, and generic competitive strategies.
- Use our business strategy case studies to understand real-life strategy applications
1.0 INTRODUCTION
Beximco Pharma was incorporated in 1976, and it is the leading manufacturer and exporter of medicines in Bangladesh. The company started its operations by importing products from Bayer, German, and USA and selling them in the local market. Beximco Pharmaceuticals Ltd. engages in the business of manufacturing and marketing generic pharmaceutical formulation products covering a wide range of therapeutic categories. The Company manufactures more than 300 products in different forms and strengths covering almost all therapeutic categories. It specializes in developing and manufacturing pharmaceutical products for various medical conditions. Among its products are antibiotics that fight infections, and medications that help patients with diabetes, respiratory problems, and gastrointestinal disorders. The company exports its products in more than fifty countries and it employs more than 4,700 employees.
Beximco Pharma has received certification from several global regulatory authorities, including the European Union, Brazil, Australia, and Gulf nations, for its high-quality manufacturing facilities. This demonstrates the company's commitment to excellence and compliance in the pharmaceutical industry.
Beximco Pharmaceuticals Ltd is the only Bangladeshi company listed on the Alternative Investment Market (AIM) of the London Stock Exchange, a platform for high-growth and innovative companies. This reflects the company's commitment to quality, innovation, and global standards (Beximco Pharmaceuticals Limited annual report 2021).
This report is going to use Beximco Pharma as the case study to examine the macro and micro environmental changes in its market. This study will use strategic frameworks such as PESTLE, SWOT, Porter's Five Forces, VRIO, and generic competitive strategies. The report will undertake a strategic overview of Beximco Pharma containing its financial performance, competitive microenvironment, competitive advantage, technological improvement, pricing strategy, and many others.